The weekly litigation news digest is live. Subscribe now

Pyrrolobenzodiazepines And Conjugates Thereof - EP2935268

The patent EP2935268 was granted to Medimmune on Feb 17, 2021. The application was filed on Dec 20, 2013 under application number EP13814939A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2935268

MEDIMMUNE
Application Number
EP13814939A
Filing Date
Dec 20, 2013
Status
Patent Maintained As Amended
Jan 15, 2021
Publication Date
Feb 17, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
JAMES POOLEAug 22, 2018WARNERADMISSIBLE

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTWO2011130598
INTERNATIONAL-SEARCH-REPORTWO2013177481
OPPOSITIONUS6362331
OPPOSITIONUS6884799
OPPOSITIONWO2011130598
OPPOSITIONWO2012112708

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents